Does Mesoblast (ASX:MSB) show Ryoncil is gaining traction? - Kalkine Media

Does Mesoblast (ASX:MSB) show Ryoncil is gaining traction? - Kalkine Media

Mesoblast reported higher Ryoncil revenue, record September patient starts and a sharp fall in cash spend in preliminary figures.

Mesoblast reported higher Ryoncil revenue, record September patient starts and a sharp fall in cash spend in preliminary figures.

This article was originally published by Kalkine Media.

Read Full Story on Source Site →
Share: